Likewise, the VEGF-A/NRP1 axis was suggested to confer cancer stem cell traits in breast cancer cells (i.e., MCF-7, MDA-MB-231) by activating the Wnt/β-catenin pathway [85]. This evidence concerns the gene NRP1 and cancer.